Entourage goes. CPhI 2025. In Frankfurt.
From October 28 - 30, 2025, the international pharmaceutical industry will meet in Frankfurt - meet our team in person on site.
From October 28 - 30, 2025, the international pharmaceutical industry will meet in Frankfurt - meet our team in person on site.
Brussels becomes the center of regulatory affairs: Discover the latest trends and strategies with our experts!
Entourage is pleased to announce its participation in DCAT Week 2025 in New York City
Entourage receives the "Top SME Employer" award from Focus Business in 2025.
Entourage is pleased to announce its participation in CPhI 2024 in Milan this year.
Entourage welcomes Dave Hickey to the Advisory Board, who will contribute his extensive experience in the medical technology industry from August 2024.
By 2035, the pharmaceutical industry faces a massive leadership gap—with consequences for innovation and competitiveness.
How to choose the most effective project methodology to ensure compliance, efficiency and successful outcomes.
Flexible QP expertise exactly when you need it. Batch releases, compliance & project support - tailor-made and ready to use.
The modern supply chain is facing immense challenges such as increasing customer demands, disruptive technologies and global uncertainty. Companies need to transform their supply chains into robust, data-driven networks in order to remain competitive.
The Covid-19 pandemic has not only exposed weaknesses in the pharmaceutical industry's global supply chain, but has also initiated a transformation. Contract Development and Manufacturing Organizations (CDMOs) in particular are faced with the task of redefining their role and creating long-term value through strategic partnerships, digitalization and sustainable innovation.
The generics and biosimilars industry is undergoing fundamental change. Technological innovations, increasing regulatory requirements and the influence of platform companies such as Amazon Pharmacy are creating new challenges and opportunities. This article shows how the industry could develop by 2030+ and which scenarios will shape manufacturers in the future.